<- Zurück zu: Unternehmensmeldungen
12.09.2012 20:00

The revocation of admission to trading on the regulated market (General Standard) pursuant to section 39 (2) of the German Stock Exchange Act (Börsengesetz) in conjunction with section 46 (1) of the Exchange Rules (Börsenordnung)

of the Frankfurt Stock Exchange shall take effect after 12 March 2013


Bitterfeld-Wolfen (Germany), 12 September 2012 - The Frankfurt Stock Exchange announced today that the application submitted by the administrator in the insolvency proceedings regarding the assets of Q-Cells SE, Mr Henning Schorisch (lawyer), for the revocation of admission to trading on the regulated market (General Standard) pursuant to section 39 (2) of the German Stock Exchange Act (Börsengesetz) in conjunction with section 46 (1) of the Exchange Rules (Börsenordnung) in respect of the shares in Q-Cells SE was accepted and that the revocation shall take effect after 12 March 2013.

Thus, with the expiry of 12 March 2013, the last remaining admission of the company's shares to trading on a regulated market also ends.


CONTACT
Q-Cells SE i.I.
OT Thalheim, Sonnenallee 17-21
06766 Bitterfeld-Wolfen, Germany
FAX +49 (0)3494 6699.10000
WEB www.q-cells.de

Q.CELLS Investor Relations
Stefan Lissner
TEL +49 (0)3494 6699.10101
EMAIL investor@q-cells.com

Q.CELLS Corporate Communications
Ina von Spies, Alberta Rohardt
TEL +49 (0)3494 6699.10121
EMAIL presse@q-cells.com

Lawyer Henning Schorisch as insolvency administrator of Q-Cells SE
Executive Board:
Dr Nedim Cen (CEO, CFO), Dr Andreas v. Zitzewitz (COO,CSO)
Chairman of the Supervisory Board: Prof Dr h c Karlheinz Hornung